Finerenone Therapy In CKD and Type 2 Diabetes

Finerenone Therapy In CKD and Type 2 Diabetes Overview The aim of this study is to assess the effect of finerenone on the duration, progression and complications of type 2 diabetes mellitus. This was achieved by estimating the values of baseline glycated hemoglobin (HbA1c) levels, glycated hemoglobin level variabilities, and the development

Stroke in the Presence of Renal Disease

Stroke in the Presence of Renal Disease Stroke is a life-threatening medical condition that occurs when blood supply to the part of the brain is cut off. It is one of the leading causes of death and disability around the world. Most strokes are caused by blockage of arteries to the

Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease?

Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease Cardiovascular diseases, including stroke, are major healthcare issues affecting humans worldwide. Between 2010 and 2030, the estimated total medical costs might escalate to from $273–$818 billion in the United States alone. Modifiable risk factors for stroke include hypertension, diabetes,

Finerenone Therapy In CKD and Type 2 Diabetes